1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BluePrints for the Community grant program (Large Grants) is sponsored by Highmark Delaware Fund, a donor-advised fund at the Delaware Community Foundation. This program supports health-related projects, programs, and supportive services in Delaware, with a preference for initiatives that increase access to healthcare for uninsured/underserved, reduce health disparities, support early childhood development, recruit/train healthcare …
Get alerted about grants like this
Save a search for “Highmark Delaware Fund, a donor-advised fund at the Delaware Community Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Highmark BCBS Delaware BluePrints for the Community Highmark Bright Blue Futures Highmark Bright Blue Futures Highmark Delaware BluePrints Highmark BCBS Delaware BluePrints for the Community In 2007, Highmark Blue Cross Blue Shield Delaware established BluePrints for the Community, a grant program to help address the issues faced by Delaware's uninsured and underserved populations.
The program was established as a donor-advised fund at the Delaware Community Foundation, a nonprofit organization that manages and administers charitable funds throughout Delaware. From inception through 2022, over 300 grants totaling more than $28 million have been awarded.
Grant proposals should aim to increase access to care and/or reduce health disparities through a program or project that falls within one of these five focus areas: For example: preventative care, disease specific, health literacy, research, etc. Economic Stability for families and individuals For example: financial resources strains, food insecurity, housing stability, etc. Social and Community Context For example: mental health, physical activities, social connections, etc. Neighborhood and Built Environment For example: safety, transportation, environmental health, infrastructure, etc. For example: training, upskilling, further education, provider practice improvements, etc. View the BluePrints for the Community 2008-2020 Impact Report .
View the BluePrints for the Community 2021 Annual Report . View the BluePrints for the Community 2022 Annual Report . View the BluePrints for the Community 2023 Annual Report .
2024 BluePrints for the Community Reports BluePrints Summary Q1 2024 BluePrints Summary Q2 2024 BluePrints Summary Q3 2024 BluePrints Summary Q4 2024 2023 BluePrints for the Community Reports BluePrints Summary Q1 2023 BluePrints Summary Q2 2023 BluePrints Summary Q3 2023 BluePrints Summary Q4 2023 Applying organization must be an incorporated not-for-profit 501c3 or community-benefit government agency, such as libraries, parks, public school districts.
BluePrints for the Community does not award grants to individuals. Applicants must disclose any conflict of interest due to representation by their organization on the BCBSD Advisory Council or Board of Directors or the Delaware Community Foundation Board of Directors. Organizations who have received BluePrints grants in the past, or have open applications in process, may still apply for funding for a different program or project.
While there are no restrictions on number of applications or awards received, application and funding history are taken into consideration. The BluePrints for the Community Large grant process is for requests above $50,000. For requests under $50,000, please continue to the ‘Small grant process’ information below.
Requests that exceed $200,000 require a meeting with BluePrints representatives prior to submission. Applications must be submitted through the Delaware Community Foundation . BluePrints for the Community Schedule Submissions for the BluePrints for the Community must be received no later than 11:59 pm on the due dates provided in this BluePrints for the Community Schedule (PDF download).
* Dates are approximate and subject to change . The BluePrints for the Community Small grant process is for requests below and up to $50,000. Applications must be submitted through the Delaware Community Foundation .
Small Grants may not be used as supplemental or gap funding for Large grants requests. Past Special Grant Cycles Social Determinants of Health Grant In 2020, we gave nearly $2 million to 17 organizations that had programs and projects focused on a variety of social determinants of health, from housing and homelessness to food insecurity and access to care.
In 2019, we made a $1 million commitment to addressing the opioid epidemic and contributed $1. 2 million to eight community partners. Questions?
Contact BluePrints for the Community representatives Non Discrimination Policy Electronic Data Interchange CMS’s Interoperability Rule Non Discrimination Policy Electronic Data Interchange CMS’s Interoperability Rule Network Access & Adequacy Network Access & Adequacy All references to “Highmark” in this document are references to the Highmark company that is providing the member’s health benefits or health benefit administration and/or to one or more of its affiliated Blue companies.
Highmark Blue Cross Blue Shield and Highmark Blue Shield are Medicare Advantage HMO, PPO, and/or Part D plans with a Medicare contract. Enrollment in these plans depends on contract renewal. Highmark Wholecare offers HMO plans with a Medicare Contract.
Enrollment in these plans depends on contract renewal. Highmark Health Options Duals offers HMO plans with a Medicare Contract. Enrollment in these plans depends on contract renewal.
®Blue Cross, Blue Shield and the Cross and Shield symbols are registered service marks of the Blue Cross Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.
The following entities, which serve the noted regions, are independent licensees of the Blue Cross Blue Shield Association: Western and Northeastern PA: Highmark Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Choice Company, Highmark Health Insurance Company, Highmark Coverage Advantage Inc., Highmark Benefits Group Inc., First Priority Health, First Priority Life Insurance Company, Highmark Care Benefits Inc., Highmark Senior Health Company, or Gateway Health Plan, Inc. d/b/a Highmark Wholecare.
Central and Southeastern PA: Highmark Inc. d/b/a Highmark Blue Shield, Highmark Benefits Group Inc., Highmark Health Insurance Company, Highmark Choice Company, Highmark Senior Health Company, or Gateway Health Plan, Inc. d/b/a Highmark Wholecare. PA: Your plan may not cover all your health care expenses. Read your plan materials carefully to determine which health care services are covered.
For more information, call the number on the back of your member ID card or, if not a member, call 866-459-4418. Delaware: Highmark BCBSD Inc. d/b/a Highmark Blue Cross Blue Shield or Highmark BCBSD Health Options Inc. d/b/a Highmark Health Options. Highmark Health Options Duals is offered by Highmark Blue Cross Blue Shield.
West Virginia: Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Health Insurance Company, Highmark Senior Solutions Company, or Highmark Health Options West Virginia Inc. d/b/a Highmark Health Options and Highmark Blue Cross Blue Shield. Highmark Health Options Duals is offered by Highmark Blue Cross Blue Shield. Visit https://www.
highmarkbcbswv. com/networkaccessplan to view the Access Plan required by the Health Benefit Plan Network Access and Adequacy Act. You may also request a copy by contacting us at the number on the back of your ID card.
Western NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Cross Blue Shield. Northeastern NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Shield.
Based on current listing details, eligibility includes: Nonprofit organizations in Delaware. Preference given to programs fitting priority areas. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies (Small Grants cannot exceed $50,000, Large Grant amount not specified) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is August 14, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.